论文部分内容阅读
儿童哮喘是一种严重影响儿童身心健康的常见呼吸道疾病。作为一种需要长期坚持治疗的慢性疾患,儿童哮喘不仅使患儿及其家长承受了很大的经济和精神负担[1-3],也为各国公共卫生机构和卫生政策的制定带来了巨大的挑战[4]。1994年世界卫生组织(WHO)和美国国立卫生研究院心肺、血液研究所在纽约召集17个国家的30多位专家,制定了具有划时代意义的全球哮喘防治创议(Global Initiative for Asthma,GINA),提出长期、持续、规范化和个体化的治疗原则。该方案实施以来,受到了全球专家的一致肯定,并且在欧美国家取得了满意效果[5],在我国按照
Childhood asthma is a common respiratory disease that severely affects children’s physical and mental health. As a chronic condition that requires long-term adherence to treatment, childhood asthma not only imposes significant financial and psychological burdens on children and their parents [1-3], but also creates a huge impact on the formulation of public health agencies and health policies in all countries The challenge [4]. In 1994, the World Health Organization (WHO) and the National Institute of Cardiopulmonary and Blood Research of the National Institutes of Health convened more than 30 experts in 17 countries in New York to develop the landmark Global Initiative for Asthma (GINA) initiative, Proposed long-term, sustainable, standardized and individualized treatment principles. Since the implementation of the program, it has been unanimously approved by global experts and has achieved satisfactory results in Europe and the United States [5]. In our country,